Arlene Bardeguez, MD, MPH, Associate Professor and Director of the Department of Obstetrics, Gynecology and Women's Health at New Jersey Medical School in Newark, discussed experience gained from the ...

Effects of immunotherapy on survival and progression-free survival in patients with splenic marginal zone lymphoma or marginal zone leukemia/lymphoma After the introduction of highly active ...

In the State of the Union address of January 2003, President George W. Bush announced an unprecedented five-year, $15 billion Emergency Plan for AIDS Relief 1 to provide highly active antiretroviral ...

A life-saving HIV breakthrough reshaped survival. But did it also reshape sexual behavior and spark an unexpected public health challenge? Study: Unintended Consequences of Life-Saving Pharmaceutical ...

HAART meds: Implications for the older adult patient Patients infected with HIV are living longer, which means they have more age-related comorbidities that require other medications as well. HOW TO ...

ALD518, a humanized anti-IL-6 antibody, treats anemia in patients with advanced non-small cell lung cancer (NSCLC): Results of a phase II, randomized, double-blind, placebo-controlled trial.

Thanks to antiretroviral therapy, HIV infection is no longer the life sentence it once was. But despite the effectiveness of drugs to manage and treat the virus, it can never be fully eliminated from ...

Dr. Lynn Paxton, MD, MPH, Chief of the Sexual Transmission and IDU Studies Section of the Centers for Disease Control and Prevention (CDC) in Atlanta, discussed the elements of domestic HIV ...